As the trial of Senate President, Dr. Bukola Saraki continues at the Code of Conduct Tribunal (CCT), several revelations from Senators lend credence to the notion that the Senate President’s trial is indeed politically motivated
Speaking on the sidelines of the trial moments after his arrival at the CCT at about 4pm, the Senate Leader, Senator Ali Ndume, told pressmen that he was just arriving at the CCT because he too was in court for politically-motivated reasons.
“This is not just about Saraki,” Ndume said, I have been at the court since 9am. They are pushing my case too to make sure they can only have people that they can control in the National Assembly leadership.”
Ndume then chatted briefly with Senator Kabiru Gaya before making his way into the tribunal.
Senator Ibrahim Gobir, representing Sokoto East, told reporters outside the tribunal sitting that Saraki was the only option for Senate President.
“Our first option is Saraki,” Gobir said, “Our second option is Saraki, and our third option is Saraki.”
Gobir, a second term Senator, and the Chairman of the Senate Services Committee, remarked that because the Senate was on recess and many legislators have traveled, the number of Senators present at the court had gone down to between 25 and 30.
“However, if it is a question of those who support Bukola Saraki,” Gobir said, “You will see about 83 to 85 Senators here.”
Meanwhile, Senator Isa Misau, the Chairman of the Senate Committee on Navy, said that officials of the executive branch were busy pushing to persecute the Senate President and have abandoned governance. Also speaking to reporters on the sidelines of the CCT, Misau said:
“The executive branch seems to have abandoned their duty, which is governance, and are instead focusing on persecuting the Senate President. This seems to be why there is fuel scarcity, and nothing seems to be working in the country.”
The trial of the Senate President has been adjourned till Monday, April 18th.
ENJOY FREE CONTENTS FROM US
IN YOUR EMAIL
Breaking News, Events, Music & More
Thank you for subscribing.
Something went wrong.